• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西早孕期子痫前期联合筛查的外部验证:一项观察性研究。

External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study.

机构信息

Clinical Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Multidisciplinary Laboratory of Epidemiology and Health - LAMPES, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.

Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Professional Master Program in Perinatal Health, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.

出版信息

Pregnancy Hypertens. 2021 Dec;26:110-115. doi: 10.1016/j.preghy.2021.10.005. Epub 2021 Oct 29.

DOI:10.1016/j.preghy.2021.10.005
PMID:
34739940
Abstract

OBJECTIVE

To validate a combined algorithm for early prediction of pre-eclampsia (PE) in the Brazilian population.

STUDY DESIGN

This is an unplanned secondary analysis of a cohort study. Consecutive singleton pregnancies undergoing first-trimester screening for PE involving examination of maternal characteristics, medical history, and biophysical markers were considered eligible. Women were classified as low-or high-risk using a cutoff of 1/200, but the individual risk was not used to dictate management, as aspirin prophylaxis was given to women based solely on clinical risk factors. Receiver-operating characteristics (ROC) curves for PE, preterm PE(PE < 37) and early 34(PE < 34) were constructed and detection rates(DR) and false-positive rates(FPR) were calculated, adjusting for the effect of aspirin. Propensity score analysis was utilized to account for possible confounding by indication.

MAIN OUTCOME MEASURES

Screening performance and PE rates.

RESULTS

Among 1695 women, 323(19.1%) were classified as high-risk for PE and 1372(80.9%) were considered low-risk. Aspirin use was registered in 62(3.7%) in the high-risk group and 33(1.9%) in the low-risk group. There were 164(9.7%) women who developed PE, including 41(2.4%) with PE < 37 and 18(1.1%) PE < 34.Subgroups with aspirin had higher incidence of PE, suggest confounding by indication. The algorithm had an AUC of 0.87, DR of 72% for PE < 34; an AUC of 0.8, DR of 59% for PE < 37, both with FPR of 18%. Accounting for effect of aspirin, we observed an improvement in DR of PE < 37 to 67%.

CONCLUSION

Using combined predictive algorithm for preterm PE prediction is feasible in clinical practice in low/middle-income countries. Aspirin use needs to be accounted for when evaluating the performance of screening.

摘要

目的

验证一种联合算法在巴西人群中对先兆子痫(PE)的早期预测。

研究设计

这是一项队列研究的计划外二次分析。连续的单胎妊娠,进行 PE 的早孕期筛查,包括检查母体特征、病史和生物物理标志物,被认为符合条件。使用 1/200 的截断值将女性分为低风险或高风险,但个体风险并未用于指导管理,因为仅根据临床危险因素向女性给予阿司匹林预防。为了调整阿司匹林的影响,构建了 PE、早产 PE(PE<37)和早 34 周 PE(PE<34)的受试者工作特征(ROC)曲线,并计算了检出率(DR)和假阳性率(FPR)。利用倾向评分分析来考虑可能存在的指示性混杂因素。

主要观察指标

筛查性能和 PE 发生率。

结果

在 1695 名女性中,323 名(19.1%)被归类为 PE 高危,1372 名(80.9%)被归类为低危。高危组中有 62 名(3.7%)女性使用了阿司匹林,低危组中有 33 名(1.9%)女性使用了阿司匹林。共有 164 名(9.7%)女性发生 PE,其中 41 名(2.4%)为 PE<37 周,18 名(1.1%)为 PE<34 周。使用阿司匹林的亚组 PE 发生率较高,提示存在指示性混杂。该算法对 PE<34 的 AUC 为 0.87,DR 为 72%;对 PE<37 的 AUC 为 0.8,DR 为 59%,两者的 FPR 均为 18%。考虑到阿司匹林的影响,我们观察到 PE<37 的 DR 提高到 67%。

结论

在中低收入国家的临床实践中,使用联合预测算法进行早产 PE 预测是可行的。在评估筛查的性能时,需要考虑阿司匹林的使用。

相似文献

1
External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study.巴西早孕期子痫前期联合筛查的外部验证:一项观察性研究。
Pregnancy Hypertens. 2021 Dec;26:110-115. doi: 10.1016/j.preghy.2021.10.005. Epub 2021 Oct 29.
2
ASPRE trial: performance of screening for preterm pre-eclampsia.ASPRE 试验:早产子痫前期筛查的表现。
Ultrasound Obstet Gynecol. 2017 Oct;50(4):492-495. doi: 10.1002/uog.18816. Epub 2017 Aug 24.
3
Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.早发型和早产子痫前期的孕早期联合筛查在 8-10 周与 11-13 周妊娠时的诊断准确性比较。
Ultrasound Obstet Gynecol. 2021 Jan;57(1):84-90. doi: 10.1002/uog.22071.
4
Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.基于母体特征和病史的双胞胎妊娠子痫前期筛查的校正竞争风险模型。
Ultrasound Obstet Gynecol. 2019 Nov;54(5):617-624. doi: 10.1002/uog.20411. Epub 2019 Oct 14.
5
Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population.在一个本土南亚人群中,胎儿医学基金会算法进行早孕期子痫前期筛查的表现。
BMC Pregnancy Childbirth. 2021 Dec 4;21(1):805. doi: 10.1186/s12884-021-04283-6.
6
ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.ASPRE 试验:尽管进行了阿司匹林预防,早产子痫前期发展的风险因素。
Ultrasound Obstet Gynecol. 2021 Oct;58(4):546-552. doi: 10.1002/uog.23668. Epub 2021 Sep 6.
7
First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort.早孕期子痫前期的预测:前瞻性入组队列中算法的外部有效性
Ultrasound Obstet Gynecol. 2014 Sep;44(3):279-85. doi: 10.1002/uog.13435. Epub 2014 Aug 13.
8
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.11-13 孕周筛查子痫前期:使用妊娠相关血浆蛋白-A、胎盘生长因子或两者联合。
Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5.
9
Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors.用母体因素对双胎妊娠子痫前期进行筛查的竞争风险模型的验证。
Ultrasound Obstet Gynecol. 2019 May;53(5):649-654. doi: 10.1002/uog.20265.
10
Predictive performance of the competing risk model in screening for preeclampsia.竞争风险模型在子痫前期筛查中的预测性能。
Am J Obstet Gynecol. 2019 Feb;220(2):199.e1-199.e13. doi: 10.1016/j.ajog.2018.11.1087. Epub 2018 Nov 14.

引用本文的文献

1
External validation of the Fetal Medicine Foundation model for preterm pre-eclampsia prediction at 11-14 weeks in an Australian population.胎儿医学基金会模型在澳大利亚人群中对11至14周早产先兆子痫预测的外部验证。
Acta Obstet Gynecol Scand. 2025 Sep;104(9):1774-1782. doi: 10.1111/aogs.70002. Epub 2025 Jul 2.
2
Performance of the first-trimester Fetal Medicine Foundation competing risks model for preeclampsia prediction: an external validation study in Brazil.孕早期胎儿医学基金会子痫前期预测竞争风险模型的性能:巴西的一项外部验证研究
AJOG Glob Rep. 2024 Mar 29;4(2):100346. doi: 10.1016/j.xagr.2024.100346. eCollection 2024 May.